Antisense Therapeutics is an Australian pharmaceutical drug discovery and development company focused on creating, developing and commercializing novel antisense therapeutics. The company’s strategy involves creating antisense drugs – in collaboration with technology and research partners – that address diseases for which there are large and/or poorly met markets; outsourcing preclinical and clinical testing of candidate drugs to expert contractors; and commercializing drugs with pre-clinical or clinical testing success through licensing deals or other partnerships with major pharmaceutical companies. For more information, visit the company’s Web site at www.antisense.com.au.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: